159 related articles for article (PubMed ID: 11594573)
21. Current management strategies for cutaneous T-cell lymphoma.
Knobler E
Clin Dermatol; 2004; 22(3):197-208. PubMed ID: 15262305
[TBL] [Abstract][Full Text] [Related]
22. Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells.
Braun FK; Fecker LF; Schwarz C; Walden P; Assaf C; Dürkop H; Sterry W; Eberle J
J Invest Dermatol; 2007 Oct; 127(10):2425-37. PubMed ID: 17495957
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous T-cell lymphomas: a review of new discoveries and treatments.
Bloom T; Kuzel TM; Querfeld C; Guitart J; Rosen ST
Curr Treat Options Oncol; 2012 Mar; 13(1):102-21. PubMed ID: 22311555
[TBL] [Abstract][Full Text] [Related]
24. [Management of cutaneous lymphoma ].
Beylot-Barry M; Battistella M
Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H13-8. PubMed ID: 21703465
[No Abstract] [Full Text] [Related]
25. New and experimental skin-directed therapies for cutaneous lymphomas.
Farkas A; Kemeny L; French LE; Dummer R
Skin Pharmacol Physiol; 2009; 22(6):322-34. PubMed ID: 19786826
[TBL] [Abstract][Full Text] [Related]
26. Standard and experimental therapy in cutaneous T-cell lymphomas.
Dummer R; Cozzio A; Meier S; Beyeler M; Laetsch B; Doebbeling U; Urosevic M
J Cutan Pathol; 2006 Feb; 33 Suppl 1():52-7. PubMed ID: 16412213
[TBL] [Abstract][Full Text] [Related]
27. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas.
Atta M; Papanicolaou N; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605
[TBL] [Abstract][Full Text] [Related]
28. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
Ferenczi K; Yawalkar N; Jones D; Kupper TS
Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma.
Wei T; Biskup E; Gjerdrum LM; Niazi O; Ødum N; Gniadecki R
Oncotarget; 2016 Jul; 7(30):48391-48400. PubMed ID: 27351221
[TBL] [Abstract][Full Text] [Related]
30. Treatment of cutaneous T-cell lymphoma: an update.
Young JW
J Am Osteopath Assoc; 1993 May; 93(5):591-8, 603. PubMed ID: 8314721
[TBL] [Abstract][Full Text] [Related]
31. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous T cell lymphoma: update of treatment.
Zackheim HS
Dermatology; 1999; 199(2):102-5. PubMed ID: 10559573
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
34. Photopheresis for cutaneous T cell lymphoma.
Heald PW
Ann N Y Acad Sci; 1991 Dec; 636():171-7. PubMed ID: 1793207
[No Abstract] [Full Text] [Related]
35. Photoinactivated lymphocyte therapy of cutaneous T-cell lymphoma.
Heald P; Knobler R; LaRoche L
Dermatol Clin; 1994 Apr; 12(2):443-9. PubMed ID: 8045055
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.
Williams VL; Torres-Cabala CA; Duvic M
Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906
[TBL] [Abstract][Full Text] [Related]
37. Optimal combination with PUVA: rationale and clinical trial update.
Stadler R
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):29-32. PubMed ID: 17474357
[TBL] [Abstract][Full Text] [Related]
38. [Interferon-alpha in cutaneous T-cell lymphoma].
Knobler R
Wien Med Wochenschr; 1993; 143(16-17):435-7. PubMed ID: 8273368
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action.
Yoo EK; Rook AH; Elenitsas R; Gasparro FP; Vowels BR
J Invest Dermatol; 1996 Aug; 107(2):235-42. PubMed ID: 8757769
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.
Dummer R; Foss F; Dreno B; Bagot M
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
